Daily life physical activity in patients with chronic stage IV sarcoidosis: A multicenter cohort study

Health Science Reports
Sarah FroidureBenoit Wallaert

Abstract

Little is known about the consequences of chronic sarcoidosis on daily life physical activity (DLPA). The aim of this prospective study was to measure DLPA in patients with chronic sarcoidosis and to determine its relationship to clinical and functional parameters. Fifty-three patients with chronic sarcoidosis and 28 healthy control subjects were enrolled in this multicenter prospective study. Two markers of DLPA (number of steps walked per day [SPD]) and total daily energy expenditure (TEE) were assessed for five consecutive days with a physical activity monitor. Pulmonary function, aerobic capacity (maximal oxygen uptake [VO2max]), exercise capacity (6-min walk test [6MWT]), and quality of life (self-reported questionnaires) were also evaluated. Comparisons of DLPA parameters between the two groups were performed using an analysis of covariance adjusted for age, sex, and body mass index (BMI). Relationships between DLPA parameters and patient characteristics were assessed in multivariable linear regression models. Patients with sarcoidosis walked significantly fewer SPD than did the control subjects (6395 ± 4119 and 11 817 ± 3600, respectively; P < 0.001 after adjustment for age, BMI, and sex). TEE was not significantly diffe...Continue Reading

References

Mar 1, 1988·Chest·D A Mahler, C K Wells
Feb 1, 1984·The American Review of Respiratory Disease·J E HansenK Wasserman
Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Dec 6, 2001·American Journal of Respiratory and Critical Care Medicine·R P BaughmanUNKNOWN Case Control Etiologic Study of Sarcoidosis (ACCESS) research group
Jul 2, 2002·American Journal of Respiratory and Critical Care Medicine·UNKNOWN ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories
Aug 7, 2004·British Journal of Health Psychology·Jolanda De VriesMarjolein Drent
Nov 3, 2005·The European Respiratory Journal·R PellegrinoJ Wanger
Oct 13, 2006·Chest·Helen J MichielsenJolanda De Vries
Jul 13, 2007·Chest·Robert P BaughmanElyse E Lower
Mar 26, 2011·The European Respiratory Journal·R G J MarcellisM Drent
Nov 15, 2011·The European Respiratory Journal·A NardiH Nunes
Jul 24, 2012·Lancet·Adrian E BaumanUNKNOWN Lancet Physical Activity Series Working Group
Nov 2, 2014·The European Respiratory Journal·Henrik WatzMartijn A Spruit
May 29, 2015·American Journal of Respiratory and Critical Care Medicine·Benjamin WaschkiHenrik Watz
Mar 3, 2017·Thorax·Ane Arbillaga-EtxarriUNKNOWN Urban Training Study Group
Jul 27, 2017·BMC Pulmonary Medicine·Thomas BahmerHenrik Watz
Aug 15, 2017·Advances in Experimental Medicine and Biology·S KostorzD Ziora
Oct 27, 2017·Advances in Experimental Medicine and Biology·K PilzakD Jastrzębski
Nov 14, 2017·Respiration; International Review of Thoracic Diseases·Thomas BahmerAnne-Marie Kirsten
Apr 8, 2018·The Lancet. Respiratory Medicine·Paolo SpagnoloAthol U Wells

❮ Previous
Next ❯

Citations

Jun 21, 2019·Current Opinion in Pulmonary Medicine·Jinny Tavee, Daniel Culver
Aug 3, 2020·Current Opinion in Pulmonary Medicine·Divya C Patel, Dominique Valeyre
Aug 1, 2019·Current Opinion in Pulmonary Medicine·Jinny Tavee, Daniel Culver
May 8, 2019·Journal of Personalized Medicine·Catharina C MoorMarlies S Wijsenbeek
Aug 28, 2020·Journal of Personalized Medicine·Marjolein DrentBert Strookappe
Feb 7, 2020·Journal of Clinical Medicine·Catharina C MoorMarlies S Wijsenbeek
Dec 29, 2020·Health Science Reports·Ingrid CamposGilles Landman

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT02044939

Software Mentioned

SenseWear
Visual
SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.